Lumida
/ACU
⌘K
Acme United Corp

Acme United Corp

ACU
$60.72USD↓-1.03%-0.63 today

MARKET CAP

232.8M

P/E (TTM)

25.8x

FWD P/E

22.5x

DAY RANGE

$60 – $61

52W RANGE

$36
$64

AI Summary

Stalk
TrimMedium

Given the dominant Stage 4 decline, medium-term bias remains bearish, recommending patience for a pullback into declining EMAs before engagement. Long-term trend remains intact bullish but non-actionable. Short-term lacks a clear edge, deferring execution until a bounce into resistance confirms timing. Overall posture is to await a more favorable entry for a directional trade aligned with the medium-term downtrend.

  • ↑Q2 net sales jumped 16% YoY to $63 M, driving net income up 5% to $5.1 M
  • ↑Gross margin improved to 42.6% in Q2, up 150 bps YoY on higher-margin first aid mix
  • ↓Q1 net income fell 40% YoY to $0.985 M as tariff and material costs surged
Full analysis →

Buying

3

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY179.76 K8.58 M+14.07 K+15.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL109.61 K5.23 M+-6.95 K-0.1%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW12.07 K576.03 K+12.07 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.46 K70.37 K+73.00+15.1%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL0.000.00+-6.95 K-100.0%0.00%